Universal Health Services Inc(UHS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 7.61 | EPS (ttm) | 24.56 | Insider Own | 17.21% | Shs Outstand | 51.7M | Perf Week | 0.97% |
| Market Cap | 11.01B | Forward P/E | 7.81 | EPS next Y | 6.1% | Insider Trans | - | Shs Float | 48.8M | Perf Month | 5.59% |
| Enterprise Value | 16.28B | PEG | 1.22 | EPS next Q | 5.19 | Inst Own | 93.59% | Short Float | 5.24% | Perf Quarter | 17.31% |
| Income | 1.53B | P/S | 0.61 | EPS this Y | 3.72% | Inst Trans | -0.4% | Short Ratio | 3.4 | Perf Half Y | 7.19% |
| Sales | 18.11B | P/B | 1.47 | EPS next 5Y | 6.42% | ROA | 9.87% | Short Interest | 2.56M | Perf YTD | -14.28% |
| Book/sh | 127.49 | P/C | 79.34 | EPS past 3/5Y | 36.2% 15.93% | ROE | 20.99% | 52W High | -24.13% ($246.32) | Perf Year | -10.42% |
| Cash/sh | 2.36 | P/FCF | 13.03 | Sales past 3/5Y | 9.03% 8.48% | ROIC | 12.79% | 52W Low | 33.42% ($140.08) | Perf 3Y | 49.54% |
| Dividend Est. | $0.82 (0.44%) | EV/EBITDA | 6.03 | EPS Y/Y TTM | 28.53% | Gross Margin | 11.36% | Volatility(W/M) | 2.5% 2.31% | Perf 5Y | 37.8% |
| Dividend TTM | 0.8 | EV/Sales | 0.9 | Sales Y/Y TTM | 10.05% | Oper. Margin | 11.36% | ATR (14) | 4.77 | Perf 10Y | 51.25% |
| Dividend Ex-Date | 2026/9/1 | Quick Ratio | 1.04 | EPS Q/Q | 10.09% | Profit Margin | 8.42% | RSI (14) | 60.86 | Recom | 2.41 |
| Dividend Gr. 3/5Y | - 31.95% | Current Ratio | 1.12 | Sales Q/Q | 8.27% | SMA20 | 3.8% ($180.05) | Beta | 1.11 | Target Price | $195.12 |
| Payout | 3.46% | Debt/Eq | 0.7 | Earnings | 2026/10/27 | SMA50 | 5.77% ($176.69) | Rel Volume | 0.6 | Prev Close | $188.13 |
| Employees | 101500 | LT Debt/Eq | 0.59 | EPS/Sales Surpr. | 0.67% 1.29% | SMA200 | 5.19% ($177.67) | Avg Volume(3M) | 0.75M | Price | $186.89 |
| IPO | 1981/7/9 | Option/Short | Yes/Yes | Trades | 9609 | Volume | 450,939 | Change | -0.66% |
🏥 A large healthcare company operating hospitals and behavioral health (mental health) facilities across the United States. It runs an extensive network of medical facilities with two main pillars — acute-care general hospitals and mental health/addiction treatment centers — making it a healthcare facility stock whose performance is tied to patient demand and the medical reimbursement environment.
Over the past 1 year, roughly in the middle
24% below its 1-year high.
Traded less than usual. That is 60% of its average volume.
Next earnings report: October 27
1 days to go.
UHS makes money exceptionally well
Of every $100 in sales, $11.36 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +3.7% this year.
Tap to view numbers
Within its industry, it looks cheap
Counting its debt, for $100 of yearly operating cash you would pay $603. Peers typically go for $1,276.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +37.8%. The S&P 500 did +68% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.44% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 93.6%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #6 of 48 in the industry
Based on market cap of $11B.
EHC#3 Encompass Health Corp $12B PER 20.2 
FMS#4 Fresenius Medical Care AG ADR $12B PER 11.7 
DVA#5 DaVita Inc $12B PER 15.5 UHS#6 Universal Health Services Inc $11B PER 7.6 
ENSG#7 Ensign Group Inc $10B PER 27.5 
FAQ
What kind of company is UHS?
UHS belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of UHS?
The market cap of UHS is approximately $11.0B, ranking 862 within its sector.
Does UHS pay dividends?
UHS has a dividend yield of approximately 0.44%, with an annual dividend of $0.82.
What is the P/E ratio of UHS?
UHS has a P/E ratio of approximately 7.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for UHS?
UHS has recorded a 52-week high of $246.32 and a low of $140.08.
